Dor Bershadsky

Why Now is the Time for HealthTech Founders to Engage with the New UK Government https://lnkd.in/dnPRU2iK > Engaging with government and policy makers is important – for ensuring you understand current or impending regulation, for getting the backing of important policy-shapers as you disrupt markets, and crucially, helping to create the soft power that can help your company’s favourability and growth. > Take a health scaleup. The Labour manifesto pledged to streamline public procurement, providing a faster route to get new products into the NHS. Incoming Secretary of State for Health and Social Care, Wes Streeting, has expressed a strong belief in the necessity of public and private collaboration for increasing efficiency and solving the NHS crisis. Engaging with Streeting’s team now could help your health tech commercially, creating a clearer path for growth. To find out more about how Founders Comms can support your startup or scaleup, get in touch at hello@founderscomms.co or check out the website here https://lnkd.in/dkgGsgNq Founders Forum Group https://lnkd.in/dnPRU2iK

6

These 7 incredible, innovative startups and founders that are pushing the limits of innovation in healthcare & therapeutics have joined the upcoming UKIB London roadshow next month led by Marius Nacht: BioGenCell LTD is pioneering cellular therapies for treating limb blood flow complications stemming from diabetes and heart disease (Yael Porat) Baccine is developing the PACMAN (Precision Anti-Cancer Microbiome Assisted Vaccination) vaccine to activate anti-cancer immunity Deborah Nejman AposHealth is developing solutions to treat gait-related conditions and musculoskeletal patients with chronic knee and back pain (Cliff Bleustein,MD,MBA) Aummune is pioneering an individualised treatment for solid tumours, tailoring a tri-functional oligonucleotide drug specifically for each patient (Irit Carmi-Levy) Curesponse is dedicated to improving the treatment journey for cancer patients and reducing the associated healthcare burdens (Guy Neev) GrayMatters Health (GMH) is revolutionising mental health care with Prism for PTSD, the first FDA-cleared neurofeedback device treating post-traumatic stress disorder (Rani Cohen) Igentify introduced the revolutionary Digital Genetic Assistant (DGA), which enables efficiency in medicine and genetic counselling while offering the most personal patient interaction in the market (Doron M Behar, MD, PhD) These groundbreaking startups will meet investors, potential customers and business partners to accelerate their path to innovation, distribution, and success. These companies are the future of global health. And it’s our pleasure to help them enable that future. Delegation London events application: UK Israel Business - The Bilateral Chamber of Commerce | Dor Bershadsky #health

46

4 Comments

techUK recently asked me to share views on #scaleup #investment challenges, which are condensed into a 3 minute blog post below. Hopefully an interesting read for UK tech entrepreneurs, VCs and policy makers... The opportunity to improve the landscape is clear. 🇬🇧

3

🚀 Kanabo: Pioneering Telemedicine and Medical Cannabis 🚀 Explore the pioneering journey of Kanabo the first medical cannabis company to list on the London Stock Exchange. Under the leadership of Ian Mattioli director of Mattioli Woods plc as chairman, Kanabo has innovated in the integration of traditional and alternative medical treatments. This video highlights how working with Ian has deepened our team’s empathy, driving significant enhancements in patient care. Discover Kanabo’s unique approach to telemedicine, combined with medical cannabis, setting new standards in healthcare innovation. #Kanabo #MedicalCannabis #Telemedicine #HealthTechInnovation #MattioliWoods

39

I couldn’t be prouder to be a Venture Partner at Isomer Capital (aka the best European FoF - at least for me) as we just announced the launch of our pioneering £100m secondaries fund. This fund is dedicated to acquiring stakes from LPs in various VC funds, tapping into a massive and largely unexplored market. 🌟 Key Highlights: - Focused Investment: Primarily targeting stakes in VC funds, with selective investments in private companies. - Robust Funding: Already over 20% funded, thanks to strong support from Nordic family offices and a German foundation. - Market Potential: With a growing number of private tech companies and a VC liquidity crunch, Europe's VC secondaries market is poised for rapid growth. - Track Record: This isn’t Isomer’s first foray into the secondaries market. As a firm we’ve done several secondaries deals with portfolio companies and VC firms, including early-stage VC Seedcamp (in 2021) and mobility giant Bolt (in 2023). - Expert Team: Welcoming the amazing Omolade (Rachel) A., formerly of Coller Capital, as a principal to lead this initiative. 💡 Investment Strategy: - 65-75% of the fund will buy "LP interest" stakes in VC funds. - 15-25% will be directed towards stakes in companies. - Up to 15% reserved for flexible investment opportunities. 📈 Looking Ahead: We're targeting returns of 2-3x, with significant distributions expected in the next 4-7 years. As one of the few players in this space, we're not just participating in the market—we're driving it forward. Read all about it here: https://lnkd.in/dc7sbC3G #VentureCapital #SecondariesFund #EuropeanVC

23

1 Comment

🌟 Scaling Care Hires: A Journey from Concept to Industry Leader 🌟 Join us as we trace the incredible evolution of Care Hires, from a mere concept on a piece of paper to a thriving platform serving over 15,000 care workers and 1,000 agencies. Ian Mattioli director of Mattioli Woods plc our first investor and chairman, played a pivotal role in this growth story, embodying the spirit of taking calculated risks to scale efficiently. In this video, explore how strategic decisions like offshoring our tech development to Sri Lanka catalyzed our expansion, enabling us to enhance service delivery and impact across the care sector. Discover the bold moves and visionary leadership that drive Care Hires ongoing success. #CareHires #HealthTechInnovation #StrategicScaling #Leadership #Entrepreneurship #MattioliWoods

22

Watching VCs start to talk about defence investments, (the way they should be talking about healthcare, education, climate change, etc), simply because it looks very profitable/opportunistic in the short-term fills me with so much cringe. The need for short term wins in EU VC sees topic/conviction hopping every 2-4y. Praying for the moonshot outliers. Fearful of being left behind with en vogue topics. Meanwhile core, painful, (often regulated) societal topics… which have so much need for disruption, well these will simply take too long or are too hard. We really need more VCs with a deeper, conviction driven, longer-term view (and suitable fund cycles / LP expectations) to invest in the massive mid-long term topics that will create the very biggest businesses & positive impact.

49

2 Comments

We are now building and growing C2Value Group, delivering value to our selected clients by improving quality and reducing costs in healthcare and public sectors

49

1 Comment

Welcome to the club! At Antler, we are proud to announce that we have just invested over £1m into nine new British tech startups. Our tenth residency in the UK attracted more than 1,100 ambitious founders, with 66 founders taking part. Representing 27 different nationalities, with women comprising 24% of the cohort, it was truly a diverse group of amazing people. Spending 10 weeks with us allowed us to undertake over 200+ hours of due diligence, helping us make high-conviction investment decisions, in which we end up investing in 1% of all applicants. We are delighted to welcome the following eight startups to Antler’s portfolio, and we’re excited to be on this journey with you! ⚙️ AlphaLoops - Automating investment management operations using AI ⚠️ BankBridge - Bridging the due diligence gap between financial institutions 🔎 Capsa AI - AI Operating System For Private Equity 📝 Falco - powered platform that empowers financial firms to identify and translate regulatory changes into actionable insights 🚚 Fleevo - The AI-driven Operating System for Modern Commercial Fleets. Driving Efficiency, Uptime, and Sustainability 🛍️ frnt - Optimising retail operations with digital workers 🎯 Intriq - Transforming businesses with the power of AI through the use of private equity playbook strategies 🦾 RoboMinder - Elevating industrial robot uptime with AI-powered computer vision In addition, Antler has made one seed investment in the first quarter of 2024, into a tech startup that is currently in stealth mode. Check out the press release in the comments section! #VentureCapital #Investments #Founders #TechStartups

298

16 Comments

The healthcare sector is therefore a key driver of climate change. 🌐 https://lnkd.in/eFtU_4Qr 🌐 ✉️ info@medicalcarbonaccreditation.com ✉️ #carbon #carbonemissions #healthcaresector #climatechange #decarbonization #environment

1

Fantastic, practical advice on fundraising at Startup Grind with Andrew Sheffield Afshin Moayed and Monty Montgomery - the VC opportunity today = cleaning up cap tables, finding exit opportunities and finding the clean sheets unaffected by the hype of recent years. Source of capital is there but taking 14 months to raise Series A - if you're building a SaaS business you will prevail where others won't. At the very early stage, a lot of exciting opportunities - need some traction or a PhD out of DeepMind... #vc #startup #investment

28

🚀 Equity crowdfunding is revolutionising investment for early-stage and scale-up businesses, offering startups an alternative funding avenue with increased brand visibility and access to a wide investor base. Explore this distinctive opportunity! 🌐 #EquityCrowdfunding #Investment #Startups #Innovation #Finance #BusinessGrowth

7

What grabs me most about Cara Health? Their stellar founding team. Their blend of medical, marketing, product, and technical expertise enables a hybrid digital/physical maternity care model validated by real insights. This talented, gritty trio can centralize fragmented solutions. With passion and vision, I believe they will thrive in femtech and make Cara Health a category leader. Impressed. The femtech market has massive potential with expected 11-15% annual growth. However, current maternity care solutions are fragmented, creating huge gaps in support for expecting mothers. 

1

HealthKey have a cool approach to things. Despite wide coverage, only around 10% of employees are using their healthcare budget 🤐 I know have never managed to use mine because every portal and page is such a mindbogglingly awful experience it's not worth the effort 👼🏻 This leaves 90% of any given healthcare budget wasted 🪦 HealthKey approaches this from the point of view that a one-size-fits-all policy is never going to meet the needs of real employees, or anybody else involved, so their approach is to use their custom API and AI tech to provide an alternative way of parsing out a more accessible and direct approach to healthcare provision for employees, employers, and healthcare providers. HealthKey has just closed a £1.13M seed round 🥳 led by Aviva Ventures, with backing from Ascension, Oxford Capital , and of course Cur8 Capital (🥰) If you want to read more about them I recommend this https://lnkd.in/eDt6THxa If you want to find more opportunities like this, I recommend you go on Cur8 Capital's app and take a poke around there - you might just find what you are looking for 👀 #healthcare #healthtech #insurtech #fintech #fundraising #venturecapital

11

1 Comment

A fascinating IBDE discussion on #AI and #Ethics, brilliantly moderated by Vivienne Artz OBE, IBDE Chair for Data and AI, with insightful contributions from participants. The meeting discussed the opportunity for #ethical #regulations in #AI, emphasising the importance of #global #standards to ensure consistency and less #industry-specific regulations. It further highlighted the potential #benefits and #challenges of AI-generated content, including the need for joined-up thinking to address ethical concerns. The meeting also discussed the importance of considering #societal #evolution and #values, #transparency, and ethical #principles in AI #decisionmaking, as well as the potential impact of AI on the media and entertainment industry.

12

1 Comment

Why Oxford Capital Invested in HealthKey... In our recent #backingfounders interview, David Tejs Jørring, co-founder of HealthKey, shares insights into the innovative digital health company that aims to simplify and enhance access to healthcare. HealthKey is described as a "digital front door" focused on preventive and proactive health, specifically designed for employers and insurers to provide a marketplace of healthcare services and products to employees. During the interview, David addresses critical questions such as why accessing healthcare through insurance is so challenging and why insurance companies are increasingly willing to pay for preventive services. Watch the interview here --> https://lnkd.in/eX2pfqg4 #VentureCapital #HealthTech #FinancialPlanning #BusinessGrowth #UKBusiness #Backingfounders #EIS

23

Looking forward to #BusinessofImpact and speaking with Jo Bautista and Owais Shafiq on all things partnerships and impact. Impact Europe Yunus Social Business Aqua for All

13

Good to see SIS Ventures EIS fund covered here by Hardman & Co The SIS Ventures EIS / SEIS Fund is open for applications! Our Fund's Information Memorandum is available to qualified investors. We are committed to backing exceptional founders, investing in high-growth businesses with global ambition. SIS Ventures are impact investors, please check out our Impact Report 👀: https://lnkd.in/eGuz6bqY for insights into our impact investing approach, portfolio and progress: ✔ SIS Ventures uses venture capital to address the most complex problems facing society and the planet, with IP-rich solutions as a force for good. ✔ Impact Reach 🌍: Growing number of our companies are gaining traction globally for their products or services. ✔ Types of Portfolio Companies we invest in, and their progress: Read about how each of our portfolio companies are growing their businesses and progressing impact. ✔ Our desire for rigour, transparency and measurement in respect of impact and sustainable investment; investment in innovation. Assuring investors of our commitment to impact investing. ✔ Ensuring fair and equitable access to venture capital, to fund the best opportunities. ✔ Sector agnostic approach: Widening our coverage across UN SDGs If you are looking to invest or understand risks further please get in touch. CAPITAL AT RISK Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more via the following link https://lnkd.in/dx3n6Q7Q #impactinvesting #venturecapital #EIS #innovation

18